HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Discriminative stimulus properties of alprazolam.

AbstractRATIONALE:
The triazolobenzodiazepine alprazolam has a unique clinical profile compared to most other benzodiazepines (e.g. diazepam, chlordiazepoxide), in that it is used to treat panic disorder and is effective in depression, two disorders that are usually treated with anti-depressants. Previous drug discrimination studies suggested that alprazolam has stimulus properties in common with antidepressants.
OBJECTIVE:
In the present study, the discriminative stimulus properties of alprazolam were investigated to test more conclusively the role of benzodiazepine receptors and whether alprazolam has stimulus properties in common with antidepressants.
METHODS:
Male Wistar rats (n=12) were trained to discriminate between alprazolam (2.0 mg/kg, PO) and vehicle in an operant two-lever drug discrimination procedure under a tandem VI40"-FR10 schedule of reinforcement. Generalization and antagonism tests were carried out under 2 min extinction.
RESULTS:
In generalization tests, a number of benzodiazepines (alprazolam, chlordiazepoxide, midazolam, lorazepam) and the barbiturate pentobarbital substituted completely, while zolpidem and abecarnil substituted partially for alprazolam. In contrast, no significant degree of generalization to the antidepressants imipramine and fluvoxamine and the putative antidepressants buspirone and flesinoxan was found. In antagonism studies alprazolam could be antagonized (almost) completely by flumazenil, partially by pentylenetetrazole, but not by methyl 6, 7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM), N-methyl-beta-carboline-3-carboxamide (FG-7142) and picrotoxin.
CONCLUSIONS:
These results show that the discriminative stimulus properties of alprazolam are mediated by benzodiazepine receptors and that the finding that antidepressants share discriminative stimulus effects with alprazolam may have limited generality.
AuthorsJ Gommans, T H Hijzen, R A Maes, B Olivier
JournalPsychopharmacology (Psychopharmacology (Berl)) Vol. 148 Issue 2 Pg. 146-52 (Feb 2000) ISSN: 0033-3158 [Print] Germany
PMID10663429 (Publication Type: Journal Article)
Chemical References
  • Anti-Anxiety Agents
  • Antidepressive Agents, Tricyclic
  • Convulsants
  • GABA Agents
  • Hypnotics and Sedatives
  • Benzodiazepines
  • Flumazenil
  • Fluvoxamine
  • Pentylenetetrazole
  • Alprazolam
Topics
  • Alprazolam (agonists, antagonists & inhibitors, pharmacology)
  • Animals
  • Anti-Anxiety Agents (agonists, antagonists & inhibitors, pharmacology)
  • Antidepressive Agents, Tricyclic (pharmacology)
  • Behavior, Animal (drug effects)
  • Benzodiazepines (pharmacology)
  • Conditioning, Operant (drug effects)
  • Convulsants (pharmacology)
  • Discrimination, Psychological (drug effects)
  • Dose-Response Relationship, Drug
  • Flumazenil (pharmacology)
  • Fluvoxamine (pharmacology)
  • GABA Agents (pharmacology)
  • Hypnotics and Sedatives (pharmacology)
  • Male
  • Pentylenetetrazole (pharmacology)
  • Rats
  • Rats, Wistar

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: